Dysfunctional Beliefs About Symptoms and Illness in Patients with Hypochondriasis

Weck, Florian; Neng, Julia M.B.; Richtberg, Samantha; Stangier, Ulrich

doi:10.1016/j.psym.2011.11.007

Cited by 58 publications

(29 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Two scores can be calculated: the SOS-CAT indicates the average probability of catastrophic outcomes, and the SOS-MIN indicates the probability of minor outcomes. The reliability and validity of the German version of the SOS was demonstrated in a previous study (see Weck et al, 2012a). In the current study, the internal consistencies (Cronbach's ) were .91 for the SOS-CAT and .67 for the SOS-MIN.…”

Section: Symptoms and Outcome Scale (Sos)mentioning

confidence: 72%

“…Both the more general evaluation of symptoms (HNST unspecific ) and the more specific evaluation of symptoms (HNST specific ) changed as a result of treatment. Regarding the HNST unspecific , only the study of Barsky et al (1993) -but not the study of Weck et al (2012a) -reported elevated scores for patients with hypochondriasis. Therefore, it is unclear whether only or both the HNST specific and the HNST unspecific assess a specific characteristic of hypochondriasis.…”

Section: Discussionmentioning

confidence: 94%

“…In the study of Barsky et al (1993), patients with hypochondriasis categorized significantly more symptoms as "no longer healthy" than non-hypochondriacal controls did. The study was replicated and expanded by Weck et al (2012a), who used the original version of the HNST and one version with more concrete instructions (i.e., "imagine yourself developing each of the following symptoms lasting for one week"). In this study, differences among patients with hypochondriasis, patients with anxiety disorders, and healthy controls emerged only when more concrete instructions were used, but differences were not observed with the original instructions for the HNST.…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

Exposure therapy changes dysfunctional evaluations of somatic symptoms in patients with hypochondriasis (health anxiety). A randomized controlled trial

Weck

Neng

Schwind

et al. 2015

Journal of Anxiety Disorders

Self Cite

View full text Add to dashboard Cite

Section: Symptoms and Outcome Scale (Sos)mentioning

confidence: 72%

Section: Discussionmentioning

confidence: 94%

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Exposure therapy changes dysfunctional evaluations of somatic symptoms in patients with hypochondriasis (health anxiety). A randomized controlled trial

Weck

Neng

Schwind

et al. 2015

Journal of Anxiety Disorders

Self Cite

View full text Add to dashboard Cite

“…These inferences, along with the inverse relationship between adverse events with depression and dementia, may seem puzzling at first given the augmented comorbidity burden and increased healthcare resource use of psychiatric patients. One hypothetical way of explaining the paradoxical decreased rate in mortality and short-term adverse events among mentally ill patients is that they may be more inclined, compared with the general population, to estimate bodily sensations and changes as indicators of a catastrophic illness [42]. Additionally, hypochondriasis is more common in patients with psychiatric disorders, especially depression [13].…”

Section: Discussionmentioning

confidence: 99%

Do Psychiatric Comorbidities Influence Inpatient Death, Adverse Events, and Discharge After Lower Extremity Fractures?

Menendez

Neuhaus

Bot

et al. 2013

Clinical Orthopaedics &Amp; Related Research

View full text Add to dashboard Cite

Background Psychiatric comorbidity is known to contribute to illness (the state of feeling unwell/unable to rely on one's body) and increased use of healthcare resources, but the effect on inpatient outcomes in fracture care is relatively unexplored. Questions/purposes Our primary null hypothesis is that a concomitant diagnosis of depression, anxiety, dementia, or schizophrenia is not associated with (1) discharge to another care facility rather than home after lower extremity fractures. Secondary study questions address the associations between psychiatric comorbidity and (2) longer inpatient stay and inpatient (3) adverse events; (4) blood transfusion; and (5) mortality after lower extremity fractures. Methods Using the National Hospital Discharge Survey database, we analyzed a total estimated number of 10,669,449 patients with lower limb fractures from 1990 to 2007. Sixty-four percent were women, and the mean ± SD age was 67 ± 22 years. The prevalence in the study population was 3.2% for depression, 1.6% for anxiety, 0.6% for schizophrenia, and 2.9% for dementia. Results A discharge diagnosis of psychiatric comorbidity was associated with a lower rate of discharge to home after accounting for an association with greater medical comorbidity (schizophrenia: odds ratio [OR], 5.6, 95% confidence interval [CI], 5.5-5.8; dementia: OR, 1.3, 95% CI, 1.2-1.3; depression: OR, 1.2, 95% CI, 1.2-1.3; anxiety: OR, 1.04, 95% CI, 1.02-1.06). Hospital stay was longer for patients with schizophrenia and dementia but shorter in patients with depression or anxiety compared with patients without any mental disorders. Schizophrenia was associated with more in-hospital adverse events and depression and anxiety with fewer events. A diagnosis of depression was associated with blood transfusion. Psychiatric comorbidity was not associated with a higher risk of in-hospital death.

show abstract

“…Several investigations have found that catastrophic thinking about bodily symptoms and overestimation of the risk of serious illness distinguishes HC from other anxiety disorders or OCD (11-17). The considerable overlap in manifestations of HC and PD has been addressed by studies showing that PD patients with HC, as compared to those without, have distinct clinical characteristics (18) and prognosis (19).…”

Section: Introductionmentioning

confidence: 99%

The Relationship of Hypochondriasis to Anxiety, Depressive, and Somatoform Disorders

et al. 2016

View full text Add to dashboard Cite

Background Though the phenotype of anxiety about medical illness has long been recognized, there continues to be debate as to whether it is a distinct psychiatric disorder and, if so, to which diagnostic category it belongs. Our objective was to investigate the pattern of psychiatric co-morbidity in hypochondriasis and to assess the relationship of health anxiety to anxiety, depressive, and somatoform disorders. Methods Data were collected as part of a clinical trial on treatment methods for hypochondriasis. 194 participants meeting criteria for DSM-IV hypochondriasis were assessed by sociodemographic variables, results of structured diagnostic interviews, and validated instruments for assessing various symptom dimensions of psychopathology. Results The majority of individuals with hypochondriasis had co-morbid psychiatric illness; the mean number of co-morbid diagnoses was 1.4, and 35.1% had hypochondriasis as their only diagnosis. Participants were more likely to have only co-morbid anxiety disorders than only co-morbid depressive or somatoform disorders. Multiple regression analysis of continuous measures of symptoms revealed the strongest correlation of health anxiety with anxiety symptoms, and a weaker correlation with somatoform symptoms; in multiple regression analysis, there was no correlation between health anxiety and depressive symptoms. Conclusion Our findings suggest that the entity of health anxiety (Hypochondriasis in DSM-IV, Illness Anxiety Disorder in DSM-5) is a clinical syndrome distinct from other psychiatric disorders. Analysis of co-morbidity patterns and continuous measures of symptoms suggest its appropriate classification is with anxiety rather than somatoform or mood disorders.

show abstract

Dysfunctional Beliefs About Symptoms and Illness in Patients with Hypochondriasis

Cited by 58 publications

References 29 publications

Exposure therapy changes dysfunctional evaluations of somatic symptoms in patients with hypochondriasis (health anxiety). A randomized controlled trial

Exposure therapy changes dysfunctional evaluations of somatic symptoms in patients with hypochondriasis (health anxiety). A randomized controlled trial

Do Psychiatric Comorbidities Influence Inpatient Death, Adverse Events, and Discharge After Lower Extremity Fractures?

The Relationship of Hypochondriasis to Anxiety, Depressive, and Somatoform Disorders

Contact Info

Product

Resources

About